- Home
- FWONA vs PODD Comparison
FWONA vs PODD Comparison
Compare FWONA & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FWONA
- PODD
- Stock Information
- Founded
- FWONA 1950
- PODD 2000
- Country
- FWONA United States
- PODD United States
- Employees
- FWONA N/A
- PODD N/A
- Industry
- FWONA Broadcasting
- PODD Medical/Dental Instruments
- Sector
- FWONA Industrials
- PODD Health Care
- Exchange
- FWONA Nasdaq
- PODD Nasdaq
- Market Cap
- FWONA 22.3B
- PODD 23.8B
- IPO Year
- FWONA N/A
- PODD 2007
- Fundamental
- Price
- FWONA $92.83
- PODD $321.18
- Analyst Decision
- FWONA Strong Buy
- PODD Strong Buy
- Analyst Count
- FWONA 2
- PODD 18
- Target Price
- FWONA $106.00
- PODD $334.50
- AVG Volume (30 Days)
- FWONA 78.1K
- PODD 539.1K
- Earning Date
- FWONA 11-06-2025
- PODD 11-06-2025
- Dividend Yield
- FWONA N/A
- PODD N/A
- EPS Growth
- FWONA N/A
- PODD N/A
- EPS
- FWONA 1.07
- PODD 3.32
- Revenue
- FWONA $3,866,000,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- FWONA $21.74
- PODD $29.18
- Revenue Next Year
- FWONA $11.38
- PODD $18.09
- P/E Ratio
- FWONA $85.02
- PODD $99.99
- Revenue Growth
- FWONA 4.71
- PODD 26.00
- 52 Week Low
- FWONA $68.00
- PODD $225.37
- 52 Week High
- FWONA $96.40
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- FWONA 54.07
- PODD 42.40
- Support Level
- FWONA $88.88
- PODD $336.00
- Resistance Level
- FWONA $92.77
- PODD $351.94
- Average True Range (ATR)
- FWONA 1.51
- PODD 10.05
- MACD
- FWONA -4.73
- PODD -3.40
- Stochastic Oscillator
- FWONA 100.00
- PODD 19.36
About FWONA Liberty Media Corporation Series A Liberty Formula One
Liberty Media Corp along with its subsidiaries is engaged in the media and entertainment industries in North America and the United Kingdom. The company owns interests in a high-quality portfolio of assets across the media, entertainment and sports industries. The company derives its maximum revenue from United Kingdom.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.